Page 182 - Pagetit
P. 182

5. GENETIC BASIS OF SUBSTANCE DEPENDENCE



                     Marteau TM, Lerman C (2001) Genetic risk and behavioural change. British
                     Medical Journal, 322:1056–1059.
                     Maruyama K et al. (1999) Genotypes of alcohol-metabolizing enzymes in relation
                     to alcoholic chronic pancreatitis in Japan. Alcoholism: Clinical and Experimental
                     Research, 23(Suppl 4):S85–S91.
                     Marzuk PM et al. (1997) Poverty and fatal accidental drug overdoses of cocaine
                     and opiates in New York City: an ecological study. American Journal of Drug and
                     Alcohol Abuse, 23:221–228.
                     Mayer P, Hollt V (2001) Allelic and somatic variations in the endogenous opioid
                     system of humans. Pharmacology and Therapeutics, 91:167–177.
                     Mayer P et al. (1997) Association between a delta-opioid receptor gene polymor-
                     phism and heroin dependence in man. Neuroreport, 8:2547–2550.
                     Meller WH et al. (1988) Specific familial transmission in substance abuse. The
                     International Journal of the Addictions, 23:1029–1039.
                     Merette C et al. (1999) Evidence of linkage in subtypes of alcoholism. Genetic
                     Epidemiology, 17(Suppl. 1):S253–S258.
                     Merikangas KR et al. (1998) Familial transmission of substance use disorders.
                     Archives of General Psychiatry, 55:973–979.
                     Merlo Pich E, Chiamulera C, Carboni L (1999) Molecular mechanisms of the
                     positive reinforcing effect of nicotine. Behavioral Pharmacology, 10:587–596.
                     Messina ES, Tyndale RF, Sellers EM (1997) A major role for CYP2A6 in nicotine C-
                     oxidation by human liver microsomes. Journal of Pharmacology and Experimental
                     Therapeutics, 282:1608–1614.
                     Michelhaugh SK et al. (2001) The dopamine transporter gene (SLC6A3) variable
                     number of tandem repeats domain enhances transcription in dopamine neurons.
                     Journal of Neurochemistry, 79:1033–1038.
                     Mihailescu S, Drucker-Colin R (2000) Nicotine, brain nicotinic receptors, and
                     neuropsychiatric disorders. Archives of Medical Research, 31:131–144.
                     Mikus G et al. (1998) Relevance of deficient CYP2D6 in opiate dependence.
                     Pharmacogenetics, 8:565–568.
                     Mirin SM et al. (1991) Psychopathology in drug abusers and their families.
                     Comprehensive Psychiatry, 32:36–51.
                     Miyamoto M et al. (1999) CYP2A6 gene deletion reduces susceptibility to lung
                     cancer. Biochemical and Biophysical Research Communications, 261:658–660.
                     Muramatsu T et al. (1996) Association between alcoholism and the dopamine
                     D4 receptor gene. Journal of Medical Genetics, 33:113–115.
                     Nakajima M et al. (1996) Role of human cytochrome P4502A6 in C-oxidation of
                     nicotine. Drug Metabolism and Disposition, 24:1212–1217.
                     Nakamura A et al. (2001) Association between catechol-O-methyltransferase
                     (COMT) polymorphism and severe alcoholic withdrawal symptoms in male
                     Japanese alcoholics. Addiction Biology, 6:233–238.
                     Nakamura K et al. (1996) Characteristics of Japanese alcoholics with the atypical
                     aldehyde dehydrogenase 2*2. I. A comparison of the genotypes of ALDH2, ADH2,


                                                     161




          Chapter_5                161                             19.1.2004, 11:46
   177   178   179   180   181   182   183   184   185   186   187